In 2019, the European Society of Cardiology and the European Atherosclerosis
Society took an important step toward reducing cardiovascular disease’s impact.
Together, the two organizations issued new guidelines aimed at effectively and
safely reducing patients’ risk through better cholesterol management.
The guidelines convey important messages about the toll of high LDL cholesterol,
the value of prevention and novel cholesterol-lowering medications, and what both
patients and health care providers can do to address this silent killer.
